Literature DB >> 2497068

A cellular and functional split in the DRw8 haplotype is due to a single amino acid replacement (DR beta ser 57- asp 57).

A K Jonsson1, L Andersson, L Rask.   

Abstract

The single DR beta chain gene of the DRw8 haplotype has been suggested to carry both the DRw8 and the DRw52 epitopes. Cellular typing has shown that the DRw8 haplotype can be split into three subtypes, Dw8.1, Dw8.2, and Dw8.3, presumably due to a polymorphism in the DRw8 beta chain. Furthermore, Dw8.1 and Dw8.2 cells present influenza virus antigen to different T-cell clones. In the present study, DRw8/Dw8.2 beta chain cDNA was cloned and characterized. A comparison of this sequence with a partial DRw8/Dw8.1 beta chain gene suggested that the DRw8 split is due to a single amino acid replacement of ser57-asp57 caused by three nucleotide substitutions in the same codon. In most DR haplotypes, two expressed DR beta chain genes exist. Comparing the nucleotide sequence of the single beta gene in the DRw8 haplotype to those of other DR beta genes revealed that the DRw8 beta gene sequence is most closely related to the DRB1 genes of the DR3, 5, and w6 haplotypes. However, the comparisons also showed that it was not possible from sequence similarities to divide the DR beta genes into two or more distinct allelic series.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2497068     DOI: 10.1007/bf00352840

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  46 in total

1.  Allelic variation in the DR subregion of the human major histocompatibility complex.

Authors:  J I Bell; D Denney; L Foster; T Belt; J A Todd; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

2.  A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules.

Authors:  J H Brown; T Jardetzky; M A Saper; B Samraoui; P J Bjorkman; D C Wiley
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

3.  Implications of the invariant gamma-chain on the intracellular transport of class II histocompatibility antigens.

Authors:  L Claesson-Welsh; P A Peterson
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

4.  Characterization of an HLA DR beta pseudogene.

Authors:  D Larhammar; B Servenius; L Rask; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

5.  DQ Wa gives rise to a DQ beta restriction fragment pattern indistinguishable from that of the DQw3.2 sub-type of DQw3.

Authors:  A Bushell; K J Wood; P J Morris
Journal:  Tissue Antigens       Date:  1988-07

6.  High-efficiency cloning of full-length cDNA.

Authors:  H Okayama; P Berg
Journal:  Mol Cell Biol       Date:  1982-02       Impact factor: 4.272

7.  Class II genes of the human major histocompatibility complex. Organization and evolutionary relationship of the DR beta genes.

Authors:  G Andersson; D Larhammar; E Widmark; B Servenius; P A Peterson; L Rask
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

8.  An improved method for isolation of H-2 and Ia alloantigens with immunoprecipitation induced by protein A-bearing staphylococci.

Authors:  S E Cullen; B D Schwartz
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

9.  High-frequency meiotic gene conversion between repeated genes on nonhomologous chromosomes in yeast.

Authors:  S Jinks-Robertson; T D Petes
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

10.  Complete sequence of an HLA-dR beta chain deduced from a cDNA clone and identification of multiple non-allelic DR beta chain genes.

Authors:  E O Long; C T Wake; J Gorski; B Mach
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  15 in total

1.  Nomenclature for factors of the HLA system, 1990. The WHO Nomenclature Committee for factors of the HLA system.

Authors: 
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

2.  Concerted evolution in a segment of the first domain exon of polymorphic MHC class II beta loci.

Authors:  L Andersson; K Gustafsson; A K Jonsson; L Rask
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  Evolutionary relationship between human major histocompatibility complex HLA-DR haplotypes.

Authors:  A C Svensson; N Setterblad; U Pihlgren; L Rask; G Andersson
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

4.  Nomenclature for factors of the HLA system, 1989. The WHO Nomenclature Committee.

Authors: 
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

5.  Human class II DNA and DOB genes display low sequence variability.

Authors:  A K Jonsson; L Rask
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

6.  Trans-species evolution of Mhc-DRB haplotype polymorphism in primates: organization of DRB genes in the chimpanzee.

Authors:  U Brändle; H Ono; V Vincek; D Klein; M Golubic; B Grahovac; J Klein
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

7.  Cruciferin gene families are expressed coordinately but with tissue-specific differences during Brassica napus seed development.

Authors:  S Sjödahl; H O Gustavsson; J Rödin; M Lenman; A S Höglund; L Rask
Journal:  Plant Mol Biol       Date:  1993-12       Impact factor: 4.076

8.  Primate DRB genes from the DR3 and DR8 haplotypes contain ERV9 LTR elements at identical positions.

Authors:  A C Svensson; N Setterblad; S Sigurdardóttir; L Rask; G Andersson
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

9.  The evolutionary origin of the HLA-DR3 haplotype.

Authors:  V Vincek; D Klein; F Figueroa; V Hauptfeld; M Kasahara; C O'hUigin; B Mach; J Klein
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

10.  Primate DRB6 pseudogenes: clue to the evolutionary origin of the HLA-DR2 haplotype.

Authors:  F Figueroa; C O'hUigin; H Inoki; J Klein
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.